CMS has not extended Part D coverage to the obesity indication for tirzepatide
These insights emphasize the need for policy changes to improve insurance coverage for individuals without type 2 diabetes, as well as strategies to manage side effects and enhance patient adherence, Ezekiel Emanuel, MD, PhD, vice provost for Global Initiatives and co-director of the Healthcare Transformation Institute, University of Pennsylvania, told Healio
If youre concerned about how your current medications are interacting, you can start a specialist consultation to review your eligibility for a combined protocol
bottom of page
2 However, patients may face issues with these medications, such as: 2 Weight-related stigma and bias Absence of generic versions for the most effective GLP-1s Availability issues due to medication shortages Lack of coverage by many insurance plans Cost of up to $1,049/month (based on average pricing* of one-month supply of 15 mg Zepbound) 3 Patients who do have insurance coverage for GLP-1s may be overwhelmed by complex prior authorization procedures and high out-of-pocket costs
Its relatively easy to switch your semaglutide injection day or catch up with any missed doses, but its important to always leave at least 48 hours in between doses and never double up on your medication
